People With Severe Diabetes Are Cured in Small Trial of New Drug Type 1 is different from the more common type 2 diabetes, which usually occurs later in life Controlling insulin levels is a constant, often costly effort Elevated blood sugar levels can damage the heart, kidneys, eyes and nerves But if levels fall too low, people can feel shaky, pass out or have seizures
Lillys oral GLP-1, orforglipron, demonstrated statistically . . . Orforglipron is the first small molecule GLP-1 to successfully complete a Phase 3 trial, lowering A1C by an average of 1 3% to 1 6% across doses The investigational once-daily oral pill reduced weight by an average 16 0 lbs (7 9%) at the highest dose in a key secondary endpoint
First Weight-Loss Pill From Lilly, Orforglipron, Shows . . . FRIDAY, April 18, 2025 — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar and lose weight